Navigation Links
Nuvilex Featured in Wall Street Reporter Interview
Date:6/10/2009

CHERRY HILL, N.J., June 10 /PRNewswire-FirstCall/ -- Nuvilex, Inc. (OTC Bulletin Board: NVLX), an emerging healthcare consumer products company, today announced that its recent marketing success with the Cinnergen product earned a Spotlight Stock feature on the Wall Street Reporter.com (www.wallstreetreporter.com).

In a recorded interview, Martin Schmieg, Chairman and CEO of Nuvilex, Inc. offers background on the company, its management team and near-term product plans.

A podcast of the interview is available at http://www.wallstreetreporter.com.

About the Wall Street Reporter

The Wall Street Reporter is a multi-media financial research and publishing company reporting to the investment community on publicly held companies since 1843. A large following of sophisticated private and institutional investors looks to the WSR to identify promising under-valued small and micro cap opportunities before the rest of the market finds them. Today the WSR reaches into the investment community across markets and continents and includes print, web, audio, streaming video, email alerts, electronic and syndicated news story distribution (including FOX and MSNBC, Money Central, Investing/Business Week), investor conferences, and CFA analyst coverage.

About Nuvilex, Inc.

Nuvilex, formerly eFoodSafety.com, is an emerging healthcare consumer products company with a portfolio of aesthetics, dermatology, environmental and nutraceutical products. The company's focus is on developing, licensing and commercializing healthcare products that address the health needs of consumers worldwide. In March 2009, Nuvilex merged wit
'/>"/>

SOURCE Nuvilex, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Nuvilex Offers Free Cinnergen Samples in Response to Spike in Consumer Interest
2. Nuvilex Launches Video Marketing Campaign
3. Nuvilex Gets Update from CK41 on purEffect(TM) Launch Plan
4. Nuvilex Signs Agreement with Jayhur Enterprises to Distribute Infinitink - the Worlds First Permanent, But Easier to Remove Tattoo Ink - in Australia and New Zealand
5. Time Magazine Reports on Infinitink Tattoo Ink From Nuvilex
6. Nuvilex, Inc. Announces Monthly Investor Conference Call
7. Nuvilex Advances Release of Citroxin(TM) Antiviral Surface Cleaner to Help Combat Swine Flu
8. Nuvilex, Inc. Announces Investor Conference Call and Open House
9. Nuvilex, Inc.s Marketing Partner, CK41 to Launch purEffect(TM) in May
10. Nuvilex, Inc. Announces New Pricing for Cinnergen and Launch of dLife Advertising and Promotion Campaign
11. Nuvilex Provides Conference Call Replay Information

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2009)...ssociation Discusses Key Provisions of Legislation...m ,, ST. CHARLES, Ill., Nov. 21 /PRNewswire-US...ves passing the landmark Affordable Health Care fo...ey health reform legislation forward, Congress has...ealth care system. Today, AARP hosted an educatio...
(Date:11/21/2009)... HAPPYneuron,s most popular and addicti...e and iPod Touch. , Mount...ron,s most popular and addictive game, SplitWords,...lit Words is designed to help banish that ,tip of ... iPhone brain game challenges the brain by encour...
(Date:11/20/2009)...neering Neurologist Closer to Understanding Brain ...ewswire-USNewswire/ -- Dr. Jeremy Schmahmann, Prof...eurologist at the Massachusetts General Hospital i...laboratory,s research on the new field of study ca...Foundation. ,, Dr. Schmahmann is an award-winni...
(Date:11/20/2009)...NCY, Mass., Nov. 20 Following a re...ompany removed from sale Shedd,s Country Crock ...hedd,s Country Crock ® Side Dishes DELUXE Fou...en. ,, The following code dates and UPCs are a...Dishes DELUXE Cheddar Broccoli Rice 21 oz, UPC 027...
(Date:11/20/2009)...ST. LOUIS, Nov. 20 Cen...at it will present at the Bank of America Merrill ...2-3, 2009, at the Crowne Plaza Hotel Times Square ...sday, December 2nd at 8:30 a.m. Eastern Time. Inve...ve, audio webcast of Centene,s presentation at: h...
Breaking Medicine News(10 mins):Health News:AARP Hosts Rep. Bill Foster In Health Care Reform Forum 2Health News:HAPPYneuron releases iPhone Brain Game 2Health News:HAPPYneuron releases iPhone Brain Game 3Health News:MINDlink Foundation Launches to Connect the Cerebellum to Cures 2Health News:Stop & Shop Alerts Customers to Voluntary Recall by Unilever 2
...ture and U.S. Department of Agriculture is investi... Douglas County. 'CDA is taking quick actio...lorado State Veterinarian John Maulsby. 'This is u... from its Colorado owner to a meat packing plant i...
...nfants were dug out from the gutter of Ratlam's Ch...erintendent P. Williams, detained earlier followin...igging continued in the compound of the hospital a...eces found Saturday night. "Two people, Will...
...shed in Archives of Otolaryngology-Head & Neck Sur...chiatric or neurologic conditions of the patient. ...had suffered dizziness for an extended period of t...e migraine or a serious brain injury and irregular...
... the first of its kind to link cholesterol with Ty... on mice, yet scientists say the findings may be a...2 diabetes is still unknown. There are varied theo...Diabetes Association estimates that more than 2 mi...
... published the first results showing that a biolog... an effective gene therapy technique. Since then h...own the viruses that cause hepatitis and HIV in mi... may be among the first to find widespread use for...
...cal Association (APA) has found evidence that the ...ung// women in advertising and media is harmful to...To complete the report, the APA Task Force on the ...ic lyrics, magazines, movies, video games and the ...
Other Medicine News:Health News:More Bones of Aborted Fetuses Recovered from Hospital Premises 2Health News:Cholesterol and Insulin Secretion -bound by a Gene 2Health News:RNAi Shows Promise in Gene Therapy 2Health News:Sexualization Linked to Mental Health Problems in Girls and Women 2
(Date:11/19/2009)...BIRMINGHAM, Ala., Nov. 19 /PRNewswire-FirstCall/ -...today announced the pricing of a public offering o...r share, resulting in gross proceeds of $48.75 mil...ryst pursuant to an effective shelf registration s...Exchange Commission. BioCryst has also granted th...
(Date:11/19/2009)...LOVELAND, Colo., Nov. 19 ...tomers, experience, Heska Corporation (Nasdaq: HS...e launch of its new and improved website. The upg...ysis, design and programming to align the site wit...ctives. ,, (Logo: http://www.newscom.com/cgi...
(Date:11/19/2009)...UNTAIN VIEW, Calif., Nov. 19 /PRNewswire-FirstCall... announced today that its corporate presentation w...affray Health Care Conference on Wednesday, Decemb...ation will be webcast from The New York Palace Hot...King, Alexza President and CEO. ,, To access ...
Breaking Medicine Technology:BioCryst Announces Pricing of Public Offering of Common Stock 2BioCryst Announces Pricing of Public Offering of Common Stock 3Heska Announces Launch of New Website 2Heska Announces Launch of New Website 3Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 2Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 3Nu Skin Celebrates Record Breaking Global Convention 60357 1Nu Skin Celebrates Record Breaking Global Convention 60357 2Nu Skin Celebrates Record Breaking Global Convention 60357 3Nu Skin Celebrates Record Breaking Global Convention 60357 4Nu Skin Celebrates Record Breaking Global Convention 60357 5ViroPharma to Present at Three November Healthcare Conferences 14654 1ViroPharma to Present at Three November Healthcare Conferences 14654 2YM BIOSCIENCES REPORTS ADDITIONAL RESULTS FROM NIMOTUZUMAB PHASE III STUDY IN CHILDREN WITH GLIOMA PRESENTED BY ONCOSCIENCE AG 14651 1YM BIOSCIENCES REPORTS ADDITIONAL RESULTS FROM NIMOTUZUMAB PHASE III STUDY IN CHILDREN WITH GLIOMA PRESENTED BY ONCOSCIENCE AG 14651 2YM BIOSCIENCES REPORTS ADDITIONAL RESULTS FROM NIMOTUZUMAB PHASE III STUDY IN CHILDREN WITH GLIOMA PRESENTED BY ONCOSCIENCE AG 14651 3YM BIOSCIENCES REPORTS ADDITIONAL RESULTS FROM NIMOTUZUMAB PHASE III STUDY IN CHILDREN WITH GLIOMA PRESENTED BY ONCOSCIENCE AG 14651 4
...zyme Substrate, CRANBURY, N.J., March 19, 2007 /PR...cal company developing,small-molecule, orally admi...ent of human genetic diseases, announced today tha... Amigal(TM) (migalastat,hydrochloride, AT1001), Am... Fabry disease, at the of Medical Genetics (ACMG),...
...today announced clinical,trial data for Seroquel s...sustained release), at the European Congress of Ps...at the SEROQUEL®,sustained release formulation...ered once daily, significantly improved symptoms,a...nd increased the,time to psychiatric relapse, when...
Other Medicine Technology:Amicus Therapeutics Presents Data From Preclinical and Phase 1,Studies of Amigal for Fabry Disease 2Amicus Therapeutics Presents Data From Preclinical and Phase 1,Studies of Amigal for Fabry Disease 3Seroquel Sustained Release Schizophrenia Data Presented at ECP,Congress in Madrid 2Seroquel Sustained Release Schizophrenia Data Presented at ECP,Congress in Madrid 3Seroquel Sustained Release Schizophrenia Data Presented at ECP,Congress in Madrid 4
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
Medicine Products: